|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30.59 USD | +2.34% |
|
-1.64% | +31.85% |
| Capitalization | 4.74B 4.08B 3.83B 3.56B 6.57B 427B 7.17B 44.55B 17.26B 202B 17.81B 17.42B 740B | P/E ratio 2025 * |
23.3x | P/E ratio 2026 * | 20.1x |
|---|---|---|---|---|---|
| Enterprise value | 5.47B 4.7B 4.41B 4.11B 7.58B 493B 8.26B 51.37B 19.91B 233B 20.54B 20.1B 853B | EV / Sales 2025 * |
0.97x | EV / Sales 2026 * | 0.87x |
| Free-Float |
92.06% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Option Care Health, Inc.
| 1 day | +2.34% | ||
| 1 week | -1.64% | ||
| Current month | -1.64% | ||
| 1 month | +10.63% | ||
| 3 months | +5.16% | ||
| 6 months | -4.11% | ||
| Current year | +31.85% |
| 1 week | 29.43 |  | 31.38 |
| 1 month | 27.19 | | 31.51 |
| Current year | 22.62 | | 35.53 |
| 1 year | 22.29 | | 35.53 |
| 3 years | 21.39 | | 35.74 |
| 5 years | 14.31 | | 35.87 |
| 10 years | 5.74 | | 35.87 |
| Manager | Title | Age | Since |
|---|---|---|---|
John Rademacher
CEO | Chief Executive Officer | 58 | 2019-08-05 |
Meenal Sethna
DFI | Director of Finance/CFO | 56 | 2025-09-30 |
Femi Adewunmi
CTO | Chief Tech/Sci/R&D Officer | 51 | 2024-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
John Rademacher
BRD | Director/Board Member | 58 | 2019-08-05 |
Timothy Sullivan
BRD | Director/Board Member | 67 | 2019-08-06 |
Elizabeth Betten
BRD | Director/Board Member | 44 | 2019-08-06 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.34% | -1.64% | +33.87% | +3.48% | 4.74B | |
| -0.32% | -4.55% | +51.73% | +103.75% | 111B | |
| +1.19% | -4.77% | +38.42% | -25.18% | 96.01B | |
| -0.31% | +0.51% | +41.28% | +79.92% | 31.16B | |
| -1.23% | +4.49% | -11.17% | +20.08% | 24.17B | |
| +0.60% | -3.29% | +11.77% | +11.24% | 21.42B | |
| -0.38% | -3.89% | +15.55% | +22.03% | 20.3B | |
| -1.76% | -4.86% | +48.49% | +366.66% | 18.46B | |
| +0.86% | -4.61% | +62.34% | +55.47% | 17.98B | |
| -2.14% | -7.18% | +16.43% | +76.50% | 14.44B | |
| Average | -0.12% | -2.77% | +30.87% | +71.39% | 35.97B | |
| Weighted average by Cap. | +0.02% | -3.50% | +37.33% | +60.19% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 5.64B 4.85B 4.55B 4.23B 7.81B 508B 8.52B 52.94B 20.52B 240B 21.16B 20.71B 879B | 6.06B 5.21B 4.89B 4.55B 8.39B 546B 9.15B 56.89B 22.05B 258B 22.74B 22.25B 945B |
| Net income | 215M 185M 174M 162M 298M 19.41B 325M 2.02B 784M 9.17B 808M 791M 33.58B | 243M 209M 196M 182M 336M 21.87B 367M 2.28B 883M 10.33B 911M 892M 37.84B |
| Net Debt | 727M 625M 587M 546M 1.01B 65.52B 1.1B 6.83B 2.65B 30.95B 2.73B 2.67B 113B | 543M 466M 438M 407M 752M 48.89B 820M 5.09B 1.97B 23.09B 2.04B 1.99B 84.59B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-08 | 30.59 $ | +2.34% | 2,305,538 |
| 25-12-05 | 29.89 $ | -0.02% | 1,420,035 |
| 25-12-04 | 29.90 $ | -1.21% | 1,720,015 |
| 25-12-03 | 30.26 $ | -1.34% | 1,940,577 |
| 25-12-02 | 30.67 $ | -0.87% | 1,556,260 |
Delayed Quote Nasdaq, December 08, 2025 at 04:00 pm EST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- OPCH Stock
Select your edition
All financial news and data tailored to specific country editions
